Mexico

Biologics exclusivity may be sacrificed to seal NAFTA 2.0 deal

Trump administration said to be considering weakening provisions to break political gridlock over USMCA

Biologics exclusivity may be sacrificed to seal NAFTA 2.0 deal
What leaked US trade talks tell us about future of UK pharma IP
4 Dec 2019

What leaked US trade talks tell us about future of UK pharma IP

Secret government documents detailing pharma patent discussions between UK and US officials have stirred up a controversy in the run up to the British general election later this month

The how's and why's of shutting out patent infringers in the Americas
4 Sep 2019

The how's and why's of shutting out patent infringers in the Americas

While injunctions are valuable instruments their availability varies widely around the world. In the first of a three-part analysis of the global landscape we focus on the three most populous countries in the Americas: the US, Mexico and Brazil

Latest

View all
7 May 2020

Regulatory framework – healthcare products and intellectual property in Mexico

With Mexico’s change of government, new trends and practices have been introduced, affecting, among other things, the regulatory and IP framework. This chapter contains an overview of the main ammendments made throughout 2019 and a brief discussion on what it is expected for 2020. Read more

3 Oct 2019

Delays in patent granting and NAFTA regulation

Read more

30 Aug 2019

Trespassing prohibited

The availability of injunctive relief varies widely around the world. In our first analysis of the global injunction landscape we lift the lid on which jurisdictions provide the best opportunity for a sales ban Read more

13 May 2019

Regulating cannabis use in Mexico – current legal framework

Mexico’s current legislation regarding cannabis use is the result of several legal actions. More than five years ago, the first legal actions regarding the prohibition of cannabis use were filed by the authorities, pushing towards a specific legal framework. Read more

Law & Policy

View all
8 Oct 2018

Life sciences innovators to gain from “new NAFTA”, but not immediately

The recently-struck deal promises to boost IP protection for pharma innovators in North America, but it will be years until it has an impact Read more

10 Sep 2018

It’s not done yet, but Trump trade deal could herald IP breakthrough for pharma innovators in Mexico

With a major focus on intellectual property, the new US-Mexico trade agreement may provide stronger data protection and patent rights Read more

25 May 2018

Modernisation of international treaties – impact on life sciences

Mexico’s statutory IP law, the Industrial Property Law (enacted in 1991 and modified in 1994), resulted from the North American Free Trade Agreement (NAFTA) negotiations with the United States and Canada and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). Read more

Litigation

View all
3 Nov 2010

Specialised IP court corrects IMPI

The examiners of the Mexican Trademark Office (IMPI) rarely analyse the distinctiveness of the different elements. However, since its creation in 2009, the IP Court of the Federal Court for Tax and Administrative Affairs has been developing criteria in this regard, thereby correcting the IMPI.

Read more

Market Developments

View all
10 Sep 2018

It’s not done yet, but Trump trade deal could herald IP breakthrough for pharma innovators in Mexico

With a major focus on intellectual property, the new US-Mexico trade agreement may provide stronger data protection and patent rights Read more

Patents Law

View all
8 Oct 2018

Life sciences innovators to gain from “new NAFTA”, but not immediately

The recently-struck deal promises to boost IP protection for pharma innovators in North America, but it will be years until it has an impact Read more

10 Sep 2018

It’s not done yet, but Trump trade deal could herald IP breakthrough for pharma innovators in Mexico

With a major focus on intellectual property, the new US-Mexico trade agreement may provide stronger data protection and patent rights Read more

25 May 2018

Modernisation of international treaties – impact on life sciences

Mexico’s statutory IP law, the Industrial Property Law (enacted in 1991 and modified in 1994), resulted from the North American Free Trade Agreement (NAFTA) negotiations with the United States and Canada and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). Read more

12 Oct 2017

The IT continuum: challenges to IP and relationship management

The Internet of Things (IoT), big data analytics and artificial intelligence (AI) are IT mega-trends that are not only evolving rapidly, but also infiltrating practically every industry, including agriculture, transformation industries, healthcare… Read more

Strategy

View all
10 Sep 2018

It’s not done yet, but Trump trade deal could herald IP breakthrough for pharma innovators in Mexico

With a major focus on intellectual property, the new US-Mexico trade agreement may provide stronger data protection and patent rights Read more

12 Oct 2017

The IT continuum: challenges to IP and relationship management

The Internet of Things (IoT), big data analytics and artificial intelligence (AI) are IT mega-trends that are not only evolving rapidly, but also infiltrating practically every industry, including agriculture, transformation industries, healthcare… Read more

2 Jul 2015

Despite patent slowdown, investor appetite for intangibles is high, says man who sold RadioShack assets

Last week the disposal of a range of intangible assets owned by RadioShack was completed, raising around $40 million for the bankrupt business. The sale included a range of trademarks, domain names and a small portfolio of 73 granted and pending…

Read more

Valuation

View all
2 Jul 2015

Despite patent slowdown, investor appetite for intangibles is high, says man who sold RadioShack assets

Last week the disposal of a range of intangible assets owned by RadioShack was completed, raising around $40 million for the bankrupt business. The sale included a range of trademarks, domain names and a small portfolio of 73 granted and pending…

Read more

Find an expert